Shingrix Revaccination and Vaccination in Vulnerable Populations
Herpes zoster, also known as shingles, is a painful cutaneous eruption that develops following the reactivation of the varicella zoster virus (VZV), the same virus that causes chickenpox.1 About 1 in 3 people in the United States will develop shingles ...
Andraos, John +2 more
core
Impaired humoral and cellular immune responses to recombinant zoster vaccine in kidney transplant recipients treated with belatacept. [PDF]
de Nattes T +5 more
europepmc +1 more source
Varicella zoster virus (VZV) infection.
• The VZV epidemiology (incidence of GP consultations, hospitalisations and deaths) is comparable to previous years. • For the prevention of herpes zoster (HZ), HZ/su (or Shingrix®) might be a promising alternative for Zostavax® due to the higher ...
Luytjes, W. +5 more
core
Evaluating varicella-zoster virus vaccine immunogenicity through Fc-mediated antibody functions: the roles of ADCP and ADCC. [PDF]
Xayaheuang S +12 more
europepmc +1 more source
Antigen-specific T<sub>H</sub>17 cells offset the age-related decline in durable T cell immunity. [PDF]
Sturmlechner I +7 more
europepmc +1 more source
Zoster-Like Dermatomal Eruption Following Recombinant Zoster Vaccine: A Case Report. [PDF]
AlZahrani RM +4 more
europepmc +1 more source
A Review of Cutaneous Viral Infections and Their Potential Role in Neurologic Diseases. [PDF]
Duque-Clavijo V, Doan HQ, Tyring SK.
europepmc +1 more source
Exploring a More Accessible and Affordable Live Attenuated Herpes Zoster Vaccine (SKYZoster<sup>®</sup>) in the Philippines. [PDF]
Cordero DA.
europepmc +1 more source
Heterologous Prime-Boost with ChAdOx1-VZV Establishes Dual-Layer Immunogenicity Conferring Protective Potential Against Herpes Zoster. [PDF]
Zhao J +6 more
europepmc +1 more source
Immunogenicity of a Recombinant Zoster Vaccine (gE/BFA01) in Mice. [PDF]
Quan Y +7 more
europepmc +1 more source

